Dergiler / Journal of the Turkish-German Gynecological Association / 2017 / Cilt: 18 - Sayı: 2

Frequency of uterine sarcomas in patients admitted for uterine fibroid surgery

Sayfa
62–66
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: In our institution, the frequency of unsuspected uterine sarcomas was 1/2269 (0.044%) among women who underwentmyomectomies and hysterectomies to treat presumed benign uterine fibroids. (J Turk Ger Gynecol Assoc 2017; 18: 62-6

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: To estimate the frequency of unsuspected uterine sarcoma identified postoperatively in women undergoing surgery for presumed enign uterine fibroids at a single university hospital.
📊
Temel Bulgular & Veri:Material and Methods: This was a retrospective single-center study; the records of all 2275 patients with uterine fibroids and uterine sarcomas from 2003 to 2015 were reviewed.
💡
Sonuç & Katkı:Conclusion: In our institution, the frequency of unsuspected uterine sarcomas was 1/2269 (0.044%) among women who underwentmyomectomies and hysterectomies to treat presumed benign uterine fibroids. (J Turk Ger Gynecol Assoc 2017; 18: 62-6
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2003 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: To estimate the frequency of unsuspected uterine sarcoma identified postoperatively in women undergoing surgery for presumed enign uterine fibroids at a single university hospital. Material and Methods: This was a retrospective single-center study; the records of all 2275 patients with uterine fibroids and uterine sarcomas from 2003 to 2015 were reviewed. Descriptive statistics were used to analyze demographic and clinical characteristics. To calculate confidence intervals (CIs), the Clopper-Pearson Exact method was applied. Results: Preoperatively, 2269 patients had presumed benign uterine fibroids, and six patients had suspected uterine sarcoma. Among the 2269 patients who underwent surgery for presumed uterine fibroids, endometrial stromal sarcoma was histopathologically revealed in only one patient [0.044%, 95% CI: (0.001-0.25)] after laparoscopic subtotal hysterectomy with morcellation. All six patients who were preoperatively diagnosed having uterine sarcoma underwent direct conventional cancer treatment. Histopathologic analyses confirmed four cases of uterine leiomyosarcoma, one high-grade undifferentiated uterine sarcoma, and one embryonal rhabdomyosarcoma. Altogether, seven women were diagnosed as having uterine sarcomas over this twelve-year period. Conclusion: In our institution, the frequency of unsuspected uterine sarcomas was 1/2269 (0.044%) among women who underwentmyomectomies and hysterectomies to treat presumed benign uterine fibroids. (J Turk Ger Gynecol Assoc 2017; 18: 62-6

🔖

Bu Makaleye Atıf Yap

MAASS, N., ABDUSATTAROVA, K., DEMPFLE, A., ALKATOUT, I., METTLER, L. (2022). Frequency of uterine sarcomas in patients admitted for uterine fibroid surgery. Journal of the Turkish-German Gynecological Association, Cilt: 18 - Sayı: 2, 62–66. https://ajindex.com/articles/567533

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Harris JA, Swenson CW, Uppal S, Kamdar N, Mahnert N, As-Sanie S, et al. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation. Am J Obstet Gynecol 2016; 214: 98 Guyon F, Cordeiro Vidal G, Babin G, Stoeckle E, Querleu D. [A critical assessment of morcellation in case of uterine malignancies and its impact on gynecologic surgery: from "precautionary principle" to "realism"]. Bull Cancer 2016; 103: 96-103.
  2. Bogani G, Chiappa V, Ditto A, Martinelli F, Donfrancesco C, Indini A, et al. Morcellation of undiagnosed uterine sarcoma: a critical review. Crit Rev Oncol Hematol 2016;98:302-8.
  3. Graebe K, Garcia-Soto A, Aziz M, Valarezo V, Heller PB, Tchabo N, et al. Incidental power morcellation of malignancy: a retrospective cohort study. Gynecol Oncol 2015; 136: 274-7.
  4. Kho KA, Lin K, Hechanova M, Richardson DL. Risk of occult uterine sarcoma in women undergoing hysterectomy for benign indications. Obstet Gynecol 2016; 127: 468-73.
  5. Bojahr B, De Wilde RL, Tchartchian G. Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH). Arch Gynecol Obstet 2015; 292: 665-72.
  6. Parker WH, Kaunitz AM, Pritts EA, Olive DL, Chalas E, Clarke-Pearson DL, et al. U.S. Food and Drug Administration's guidance regarding morcellation of Leiomyomas: well-intentioned, but is it harmful for women? Obstet Gynecol 2016; 127: 18-22.
  7. Pritts EA, Vanness DJ, Berek JS, Parker W, Feinberg R, Feinberg J, et al. The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis. Gynecol Surg 2015; 12: 165-77.
  8. Picerno TM, Wasson MN, Gonzalez Rios AR, Zuber MJ, Taylor NP, Hoffman MK, et al. Morcellation and the incidence of occult uterine malignancy: a dual-institution review. Int J Gynecol Cancer 2016; 26: 149-55.
  9. Hur HC, King LP, Klebanoff MJ, Hur C, Ricciotti HA. Fibroid morcellation: a shared clinical decision tool for mode of hysterectomy. Eur J Obstet Gynecol Reprod Biol 2015; 195: 122-7.
  10. Park JY, Park SK, Kim DY, Kim JH, Kim YM, Kim YT, et al. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. Gynecol Oncol 2011; 122: 255-9.
  11. George S, Barysauskas C, Serrano C, Oduyebo T, Rauh-Hain JA, Del Carmen MG, et al. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma. Cancer 2014; 120: 3154-8.
  12. Nagai T, Takai Y